Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2011

View Archived Issues

Expanded data presented from ORACAL trial of oral versus nasal salmon calcitonin

Study identifies SNPs linked to remission and response to bupropion and placebo for depression

Orexigen receives design requirements from FDA for cardiovascular outcomes trial of Contrave

Results presented from ENCORE 301 study of exemestane plus entinostat in advanced breast cancer

Bristol-Myers Squibb and Ono enter agreement for Orencia and BMS-936558/ONO-4538

Findings disclosed from post hoc subanalysis of SYNCHRONY study

Cyclic lipopeptide shows promise to treat CDI-associated diarrhea in phase II trial

New phase I data disclosed on Pennvax-B HIV vaccine plus Genevax-IL12

European Commission approves Orion's sedative dexdor

Promising results reported on ProtoKinetix antiaging glycopeptide

Enrollment begins in phase III TOviTO program

OX-219 shows promise in patients with opioid dependence

European Commission approves Incivo

University of Pittsburgh presents new anticancer agents

ARIAD Pharmaceuticals advances phase I/II AP-26113 trial

Boehringer Ingelheim discloses novel Mnk inhibitors

Novel anticancer furoxan derivatives synthesized

New histone deacetylase inhibitors prepared by Millennium Pharmaceuticals

Aragon Pharmaceuticals describes new androgen receptor ligands

Nihon Medi-Physics begins phase III trial of imaging agent NMA-78

Repros Therapeutics' study of low-dose oral Proellex advances

Ariel Pharmaceuticals in-licenses lead product for acute migraine from BTG

Trident Pharmaceuticals' HF-1020 enters first-in-human trial

MSD launches Cubicin in Japan

European orphan drug designation granted to Pfizer's TB product candidate

F-647 approved in China

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...